Open access
Sep 2026
New Chromene Derivatives as Promising VEGFR‐2 Inhibitors: Experimental Cytotoxicity and Comprehensive Computational Characterization
Experimental and computational findings identify compound 17 as a promising and mechanistically well‐characterized VEGFR‐2 inhibitor, warranting further in vivo investigation.
Hazem Elkady, Aisha A. Alsfouk, E. Elkaeed et al.
· Archiv der Pharmazie · 0 citations